Status:
UNKNOWN
Evaluation of the Respiratory Impact After Conventional or Minimally Invasive Esophageal Atresia Surgery
Lead Sponsor:
University Hospital, Angers
Collaborating Sponsors:
Institut de Recherche en Santé, Environnement et le Travail, France
Filière des Maladies Rares Abdomino-THOraciques : FIMATHO
Conditions:
Esophageal Atresia
Oesophageal Atresia
Eligibility:
All Genders
Brief Summary
Right thoracotomy, conventional approach to esophageal atresia repair, leads to up to 60% radiological chest wall sequelae anomalies. The impact of these anomalies on the patient's respiratory functio...
Detailed Description
Right thoracotomy, conventional approach to esophageal atresia repair, leads to up to 60% radiological chest wall sequelae anomalies. The impact of these anomalies on the patient's respiratory functio...
Eligibility Criteria
Inclusion
- Patients included in the national esophageal atresia registry (CRACMO)
- Operation for type III esophageal atresia (Ladd classification)
- Between 01/01/2008 and 31/12/2013.
Exclusion
- Long gap esophageal atresia
- Patients lost to follow up
- Deceased
- No PFTs or X-rays between 6 and 9 years of follow up
- Patients having had thoracic surgery before the esophageal atresia repair
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04136795
Start Date
January 1 2020
End Date
December 1 2020
Last Update
December 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CRACMO - centre de référence des atrésies de l'oesophage
Lille, France, 59000